Inventor

MEERPOEL LIEVEN

BE97 patents

⚠️ This page may combine multiple inventors who share the name “MEERPOEL LIEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MEERPOEL LIEVEN

JANSSEN PHARMACEUTICA NV

Inhibitors of histone deacetylase

Sulfonyl-derivatives as novel inhibitors of histone deacetylase

Inhibitors of histone deacetylase

Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase

Sulfonyl-derivatives as novel inhibitors or histone deacetylase

Sulfonyl-Derivatives as novel inhibitors of histone deacetylase

Polyarylcarboxamides useful as lipid lowering agents

Angiogenesis inhibiting pyridazinamines

MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles

MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles

Spirobicyclic analogues

6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors

Inhibitors of histone deacetylase

Biphenylcarboxamides useful as lipid lowering agents

Spirobicyclic analogues

6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors

Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer

Substituted thiohydantoin derivatives as androgen receptor antagonists

Deuterated triazolopyridazine as a kinase modulator

Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines

Polyarylcarboxamides useful as lipid lowering agents

Polyarylcarboxamides useful as lipid lowering agents

Amino acid ester containing azole antifungals

6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors

Piperidine/piperazine derivatives

Biphenylcarboxamides useful as lipid lowering agents

Spirobicyclic analogues

Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors

(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity

Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors

Substituted thiohydantoin derivatives as androgen receptor antagonists

ASTEX THERAPEUTICS LTD

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

Pyrazolyl quinoxaline kinase inhibitors

Pyrazolyl quinoxaline kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Quinazolinone derivatives useful as FGFR kinase modulators

Pyrazolyl quinoxaline kinase inhibitors

EMELEN KRISTOF VAN

Sulfonyl-derivatives as novel inhibitors of histone deacetylase

Inhibitors of histone deacetylase

Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase

Sulfonyl-derivatives as novel or histone deacetylase

Sulfonyl-derivatives as novel inhibitors of histone deacetylase

(unassigned)

Biocidal benzylbiphenyl derivatives

Water soluble azoles as broad-spectrum antifungals

MEERPOEL LIEVEN

Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compounds

N-aryl piperidine substituted biphenylcarboxamides

ANGIBAUD PATRICK RENE

Inhibitors of histone deacetylase

SAXTY GORDON

Pyrazolyl quinoxaline kinase inhibitors